Calumet (CLMT) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CLMT SEC filings page.
Calumet, Inc. (CLMT) reported $4.6B in revenue over the twelve months to Jun 30, 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Despite nearly unchanged revenue, FY2025 restored cash generation, but the business remains financed by liabilities exceeding assets.
FY2025 converted operations into$108.9M of cash from an operating cash outflow of$46.4M in FY2024, a reversal that matters more than the nearly flat top line. With$52.3M of capital spending, the business produced$56.6M of free cash flow, showing that the improvement reflected both better operating cash generation and lighter reinvestment.
Revenue declined
Liabilities equaled
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Calumet, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Calumet, Inc. has an operating margin of 2.6%, meaning the company retains $3 of operating profit per $100 of revenue. This results in a moderate score of 38/100, indicating healthy but not exceptional operating efficiency. This is up from 0.2% the prior year.
Calumet, Inc.'s revenue declined 1.2% year-over-year, from $4.2B to $4.1B. This contraction results in a growth score of 28/100.
Calumet, Inc.'s current ratio of 1.02 is below the typical benchmark, resulting in a score of 19/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Calumet, Inc.'s free cash flow margin of 1.4% results in a low score of 23/100. Capital expenditures of $52.3M absorb a large share of operating cash flow.
Calumet, Inc. scores 1.73, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $1.6B against total assets of $2.7B. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Calumet, Inc. passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
Calumet, Inc. reported a net loss of $33.8M while generating $108.9M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Calumet, Inc. earns $0.50 in operating income for every $1 of interest expense ($108.7M vs $215.8M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Calumet, Inc. generated $1.4B in revenue in Q2 2026. This represents an increase of 40.8% from the same quarter a year earlier. Against the prior quarter it is up 40.3%.
Calumet, Inc.'s EBITDA was $5.5M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Calumet, Inc. reported a net loss of $95.9M in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Calumet, Inc. earned -$1.09 per diluted share (EPS) in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
Calumet, Inc. generated $54.0M in free cash flow in Q2 2026, representing cash available after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Calumet, Inc. held $109.8M in cash against $2.2B in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Calumet, Inc.'s gross margin was 1.3% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 5.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 9.8 percentage points.
Calumet, Inc.'s operating margin was -2.8% in Q2 2026, reflecting core business profitability. This is up 7.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 13.9 percentage points.
Calumet, Inc.'s net profit margin was -6.6% in Q2 2026, showing the share of revenue converted to profit. This is up 7.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 24.1 percentage points.
Not reported for Q2 2026.
Capital Allocation
Calumet, Inc. invested $38.3M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 101.6% from the same quarter a year earlier. Against the prior quarter it is up 190.2%.
Not reported for Q2 2026.
Not reported for Q2 2026.
CLMT Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4B+40.8% | $1.0B+3.6% | $1.0B | $1.1B-2.0% | $1.0B | $993.9M-1.2% | N/A | $1.1B-4.3% |
| Cost of Revenue | $1.4B+33.3% | $1.1B+3.9% | $1.0B | $704.3M-35.7% | $1.1B | $1.1B+16.0% | N/A | $1.1B+23.4% |
| Gross Profit | $18.3Mn/m | -$87.5Mn/m | -$3.0M | $373.7M+7526.5% | -$43.6M | -$81.4M-203.7% | N/A | $4.9M-98.1% |
| SG&A Expenses | $52.9M-0.8% | $78.3M+220.9% | $51.7M | $42.3M-23.2% | $53.3M | $24.4M-34.1% | N/A | $55.1M+4.8% |
| Operating Income | -$40.0Mn/m | -$171.3Mn/m | -$64.5M | $322.9Mn/m | -$101.0M | -$48.7M-234.2% | N/A | -$57.1M-126.8% |
| EBITDA | $5.5Mn/m | -$138.3Mn/m | -$51.3M | $373.6Mn/m | -$53.1M | -$11.7M-114.3% | N/A | -$11.8M-104.6% |
| Interest Expense | $52.0M-1.7% | $51.1M-12.6% | $50.8M | $53.6M-7.1% | $52.9M | $58.5M-3.8% | N/A | $57.7M-1.7% |
| Income Tax | -$21.2M-10700.0% | -$20.8M-5300.0% | -$51.8M | -$41.4M-6014.3% | $200K | $400K+100.0% | N/A | $700K+40.0% |
| Net Income | -$95.9Mn/m | -$317.0Mn/m | -$37.3M | $313.4Mn/m | -$147.9M | -$162.0Mn/m | N/A | -$100.6M-200.8% |
| EPS (Basic) | -$1.09n/m | -$3.64n/m | -$0.43n/m | $3.61n/m | -$1.70n/m | -$1.87n/m | -$0.46 | -$1.18-195.2% |
| EPS (Diluted) | -$1.09n/m | -$3.64n/m | -$0.43n/m | $3.61n/m | -$1.70n/m | -$1.87n/m | -$0.46 | -$1.18-195.2% |
| Diluted Shares (Avg) | 88M+0.9% | 87M+0.7% | N/A | 87M+1.6% | 87M+7.7% | 86M+7.6% | N/A | 86M+6.4% |
Not reported in any period shown, so not listed: R&D Expenses.
CLMT Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.8B+1.0% | $2.8B-2.4% | $2.7B-2.5% | $2.7B+3.6% | $2.8B+2776399900.0% | $2.8B | $2.8B+0.3% | $2.6B |
| Current Assets | $1.0B+14.2% | $927.9M+1.1% | $857.8M+12.0% | $880.1M+11.4% | $895.8M+895799900.0% | $917.9M | $766.0M-3.6% | $789.8M |
| Cash & Equivalents | $109.8M-0.7% | $138.6M+12.3% | $125.1M+228.3% | $94.6M+173.4% | $110.6M | $123.4M+416.3% | $38.1M+382.3% | $34.6M+152.6% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0 | $0n/m | $0n/m | $0n/m |
| Inventory | $421.0M+13.6% | $369.5M-5.1% | $385.2M-7.5% | $400.1M-2.3% | $370.5M | $389.4M | $416.3M-5.3% | $409.5M |
| Accounts Receivable | $417.0M+53.8% | $358.4M+27.4% | $224.4M-7.2% | $263.9M-5.6% | $271.1M | $281.4M | $241.7M-4.2% | $279.6M |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0 | $0n/m | $0n/m | $0n/m |
| Goodwill | N/A | N/A | $140.5M-18.8% | N/A | N/A | N/A | $173.0M0.0% | N/A |
| Total Liabilities | $3.7B+4.2% | $3.5B+3.1% | $3.2B-1.5% | $3.2B+3.8% | $3.5B+525.1% | $3.4B | $3.2B+7.6% | $3.1B |
| Current Liabilities | $1.2B+3.5% | $963.1M+10.8% | $840.7M-2.7% | $776.3M-38.1% | $1.2B | $869.1M | $863.6M-22.4% | $1.3B |
| Non-Current Liabilities | $2.5B+4.6% | $2.6B+0.5% | $2.3B-1.1% | $2.4B+32.8% | $2.4B | $2.6B | $2.4B+25.4% | $1.8B |
| Long-Term Debt | $2.2B+5.7% | $2.3B-0.1% | $2.1B+0.6% | $2.1B+29.4% | $2.1B | $2.3B | $2.1B+12.8% | $1.7B |
| Total Equity | -$1.1Bn/m | -$1.0Bn/m | -$732.7Mn/m | -$695.3Mn/m | -$1.0Bn/m | -$862.3Mn/m | -$711.9Mn/m | -$672.2Mn/m |
| Retained Earnings | -$2.0Bn/m | -$1.9Bn/m | -$1.6Bn/m | -$1.5Bn/m | -$1.8B | -$1.7B | -$1.5Bn/m | -$2.2B |
CLMT Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $92.3Mn/m | -$86.2Mn/m | $116.5Mn/m | $23.5Mn/m | -$1.8M | -$29.3Mn/m | -$3.4Mn/m | -$15.5M |
| Depreciation & Amortization | $45.5M-5.0% | $33.0M-10.8% | $13.2M | $50.7M+11.9% | $47.9M | $37.0M-18.5% | N/A | $45.3M+3.9% |
| Stock-Based Compensation | N/A | $37.4Mn/m | N/A | N/A | N/A | -$21.5M | N/A | N/A |
| Capital Expenditures | $38.3M+101.6% | $13.2M-25.0% | $12.7M-49.2% | $23.5M+21.1% | $19.0M | $17.6M-12.0% | $25.0M-20.6% | $19.4M-59.6% |
| Free Cash Flow | $54.0Mn/m | -$99.4Mn/m | $103.8Mn/m | $0n/m | -$20.8M | -$46.9Mn/m | -$28.4Mn/m | -$34.9M |
| Investing Cash Flow | -$39.3Mn/m | -$13.7M-117.6% | -$11.7Mn/m | -$8.4Mn/m | -$13.6M | $77.8Mn/m | -$25.0Mn/m | -$16.7M |
| Financing Cash Flow | -$81.8M-3246.2% | $73.4M-32.7% | -$74.3M-332.2% | -$31.1M-151.9% | $2.6M | $109.0M-16.6% | $32.0M-3.9% | $59.9M |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
CLMT Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 1.3%+5.5pp | -8.5%-0.3pp | -0.3% | 34.7%+34.2pp | -4.3% | -8.2%-16.0pp | N/A | 0.4%-22.3pp |
| Operating Margin | -2.8%+7.1pp | -16.6%-11.7pp | -6.2% | 29.9%+35.1pp | -9.8% | -4.9%-8.5pp | N/A | -5.2%-23.7pp |
| Net Margin | -6.6%+7.8pp | -30.8%-14.5pp | -3.6% | 29.1%+38.2pp | -14.4% | -16.3%-12.2pp | N/A | -9.1%-17.8pp |
| Return on Assets | -3.4%+1.9pp | -11.5%-5.8pp | -1.4% | 11.5%+15.3pp | -5.3% | -5.7% | N/A | -3.8% |
| Current Ratio | 0.84+0.1x | 0.96-0.1x | 1.02+0.1x | 1.13+0.5x | 0.76 | 1.06 | 0.89+0.2x | 0.63 |
| Asset Turnover | 0.52+0.1x | 0.370.0x | 0.39 | 0.390.0x | 0.37 | 0.35 | N/A | 0.42 |
| FCF Margin | 3.7%+5.8pp | -9.7%-4.9pp | 10.0% | 0.0%+3.2pp | -2.0% | -4.7%+6.6pp | N/A | -3.2% |
Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, Liabilities-to-Equity.
Note: Shareholder equity is negative (-$732.7M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Calumet, Inc. CLMT | FY2025 | $4.1B | -$33.8M | -0.8% | $4.6B | 27/100 |
| Stepan Co. SCL | FY2025 | $2.3B | $46.9M | 2.0% | $1.5B | 38/100 |
| Ecovyst Inc. ECVT | FY2025 | $723.5M | -$71.1M | -9.8% | $1.1B | 64/100 |
| Oil-Dri Corporation of America ODC | FY2026 | $493.8M | $57.0M | 11.5% | $1.1B | 68/100 |
| Kronos Worldwide, Inc. KRO | FY2025 | $1.9B | -$110.9M | -6.0% | $875.9M | 36/100 |
Where Calumet, Inc. Ranks
Frequently Asked Questions
What is Calumet, Inc.'s annual revenue?
Calumet, Inc. (CLMT) reported $4.1B in total revenue for fiscal year 2025. This represents a -1.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Calumet, Inc.'s revenue growing?
Calumet, Inc. (CLMT) revenue declined by 1.2% year-over-year, from $4.2B to $4.1B in fiscal year 2025.
Is Calumet, Inc. profitable?
No, Calumet, Inc. (CLMT) reported a net loss of $136.8M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net loss of $33.8M, with a net profit margin of -0.8%.
What is Calumet, Inc.'s EBITDA?
Calumet, Inc. (CLMT) had EBITDA of $257.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Calumet, Inc. have?
As of fiscal year 2025, Calumet, Inc. (CLMT) had $125.1M in cash and equivalents against $2.1B in long-term debt.
What is Calumet, Inc.'s gross margin?
Calumet, Inc. (CLMT) had a gross margin of 5.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Calumet, Inc.'s operating margin?
Calumet, Inc. (CLMT) had an operating margin of 2.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Calumet, Inc.'s net profit margin?
Calumet, Inc. (CLMT) had a net profit margin of -0.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Calumet, Inc.'s free cash flow?
Calumet, Inc. (CLMT) generated $56.6M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Calumet, Inc.'s operating cash flow?
Calumet, Inc. (CLMT) generated $108.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Calumet, Inc.'s total assets?
Calumet, Inc. (CLMT) had $2.7B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Calumet, Inc.'s capital expenditures?
Calumet, Inc. (CLMT) invested $52.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Calumet, Inc.'s current ratio?
Calumet, Inc. (CLMT) had a current ratio of 1.02 as of fiscal year 2025, which is considered adequate.
What is Calumet, Inc.'s return on assets (ROA)?
Calumet, Inc. (CLMT) had a return on assets of -1.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Calumet, Inc.'s P/E ratio?
Calumet, Inc. (CLMT) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $4.6B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Calumet, Inc.'s price-to-sales ratio?
Calumet, Inc. (CLMT) trades at 1.0x sales, its market capitalization divided by $4.6B revenue, trailing 12 months to June 30, 2026. The market capitalization is $4.6B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Why is Calumet, Inc.'s debt-to-equity ratio negative or not reported?
Calumet, Inc. (CLMT) has negative shareholder equity of -$732.7M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Calumet, Inc.'s Altman Z-Score?
Calumet, Inc. (CLMT) has an Altman Z-Score of 1.73, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Calumet, Inc.'s Piotroski F-Score?
Calumet, Inc. (CLMT) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Calumet, Inc.'s earnings high quality?
Calumet, Inc. (CLMT) reported a net loss of $33.8M while generating $108.9M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Calumet, Inc. cover its interest payments?
Calumet, Inc. (CLMT) has an interest coverage ratio of 0.50x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Calumet, Inc.?
Calumet, Inc. (CLMT) scores 27 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.